Government Performance and Results Act (GPRA)
For more information about GPRA, including results prior to 2017 please click the link below:
For more information about the 2023 measures, including measure logic please click the link below:
-
Historical Summary Reports
To view the historical reports, the following pages are available.
- GPRA Report Summary 2023
A continuing emphasis on community oral health promotion/disease prevention is essential in order to address the current high prevalence, reduce the severity of oral disease and improve the oral health of American Indian/Alaska Native (AI/AN) people.
The IHS dental health measures support Healthy People 2030 oral conditions objectives.
Access to dental services is a prerequisite for the control of oral disease in susceptible or high-risk populations.
Topical fluorides and dental sealants have been extensively researched and documented in the dental literature as safe and effective preventive interventions to reduce tooth decay.
ACCESS TO DENTAL SERVICES
DENTAL SEALANTS
2023 Final Result
TOPICAL FLUORIDE
2023 Final Result
Diabetes prevention and treatment efforts are important priorities to decrease the onset of diabetes and its complications.
Controlling blood pressure reduces the risk that diabetic patients will develop heart disease, stroke, and kidney failure.
Adequate control of blood sugar levels reduces the risk that patients will develop complications of diabetes, such as heart, blood vessel, eye, kidney, and nerve problems.
Nephropathy assessments help to identify patients who are at risk for kidney disease.
Retinopathy assessments help to identify diabetic patients who are at higher risk for developing blindness.
People with diabetes have an increased risk of heart disease and stroke. Medications called statins help reduce this risk.
CONTROLLED BLOOD PRESSURE <140/90
POOR GLYCEMIC CONTROL
2023 Final Result
NEPHROPATHY ASSESSED
2023 Final Result
RETINOPATHY EXAM
2023 Final Result
STATIN THERAPY
2023 Final Result
Routine immunizations represent a cost-effective public health approach to protect individuals from preventable infectious diseases.
IHS tracked four immunizations nationally in 2023.
Two measures targeted children: combined (4:3:1:3:3:1:4) childhood series for children 19 – 35 months and an annual influenza vaccination for children 6 months to 17 years.
Two adult vaccination measures are included: annual influenza vaccination for adults 18+ and an adult composite immunization.
CHILDHOOD IMMUNIZATIONS
INFLUENZA VACCINATION 6 MO-17 YRS
2023 Final Result
INFLUENZA VACCINATION 18+
2023 Final Result
ADULT COMPOSITE IMMUNIZATION
2023 Final Result
Prevention measures focus attention on early detection of disease (cancer screenings) and management of risk factors to prevent disease (tobacco cessation and HIV screening).
Prevention can focus on appropriate treatment of chronic conditions (cholesterol and blood pressure treatment) to avoid complications.
Prevention also focuses on healthy behaviors/lifestyles (childhood weight control and infant breastfeeding) that have been shown to prevent diseases.
(CERVICAL) PAP SCREENING
COLORECTAL CANCER SCREENING
2023 Final Result
MAMMOGRAPHY SCREENING
2023 Final Result
TOBACCO CESSATION
2023 Final Result
HIV SCREENING EVER
2023 Final Result
CVD STATIN THERAPY
2023 Final Result
CONTROLLING HIGH BLOOD PRESSURE-MILLION HEARTS
2023 Final Result
CHILDHOOD WEIGHT CONTROL
2023 Final Result
BREASTFEEDING RATES
2023 Final Result
High rates of alcohol and substance abuse, mental health disorders, suicide, violence, and behavior-related chronic diseases in American Indian and Alaska Native communities are well documented.
Each of these serious behavioral health issues has a profound impact on the health of individuals, families, and communities.
Two measures relate to alcohol screening or identifying patients with risky or harmful alcohol use and provide them with a brief negotiated interview.
Two depression screening measures span ages 12 and older.
The intimate partner (domestic) violence (IPV/DV) measure identifies women 14 – 46 years who have been screened for IPV/DV.
UNIVERSAL ALCOHOL SCREENING
SCREENING, BRIEF INTERVENTION & REFERRAL TO TREATMENT
DEPRESSION SCREENING 12-17 YRS
DEPRESSION SCREENING 18+
INTIMATE PARTNER VIOLENCE/ DOMESTIC VIOLENCE SCREENING
No matching content found.
GPRA/GPRAMA National and Area Results
- FY 2023 GPRA/GPRAMA National and Area Results [PDF - 4 MB]
- FY 2022 GPRA/GPRAMA National and Area Results [PDF - 4 MB]
- FY 2021 GPRA/GPRAMA National and Area Results [PDF - 4 MB]
- FY 2020 GPRA/GPRAMA National and Area Results [PDF - 4 MB]
- FY 2019 GPRA/GPRAMA National and Area Results [PDF - 228 KB]
- FY 2018 GPRA/GPRAMA National and Area Results [PDF - 2 MB]
- FY 2017 GPRA/GPRAMA National and Area Results [PDF - 2 MB]